PolarityTE: Funding, Investors & Team (Sep 2026)
PolarityTE is dedicated to revolutionizing patient care through the discovery, creation, and advancement of regenerative tissue products and biomaterials in the fields of medicine, biomedical engineering, and material sciences. Instead of using artificial materials in lab settings, PolarityTE utilizes the patient's own tissue and body to facilitate the regenerative process. By utilizing a small piece of the patient's own healthy tissue, the company produces a versatile and self-sustaining product that aims to regenerate specific tissues. PolarityTE's innovative approach is designed to enhance and accelerate the healing process through natural tissue growth.
PolarityTE has raised $20.5M across 2 funding rounds on record, the most recent an undisclosed round of $12.5M announced in May 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PolarityTE Company Profile and Key Stats
Latest funding round on record: May 2024.
PolarityTE Funding Rounds
PolarityTE raised $8.0M in a Post-IPO Equity announced in Jun 2022.
1.9 years later, an undisclosed round of $12.5M was announced in May 2024.
PolarityTE Founders and Leadership Team
No contact details are on record for this team yet.
PolarityTE Funding Compared to Other Biotechnology Startups
PolarityTE's latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PolarityTE in Biotechnology and Salt Lake City
Companies Similar to PolarityTE
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
PolarityTE Funding FAQs
What does PolarityTE do?
PolarityTE is dedicated to revolutionizing patient care through the discovery, creation, and advancement of regenerative tissue products and biomaterials in the fields of medicine, biomedical engineering, and material sciences. Instead of using artificial materials in lab settings, PolarityTE utilizes the patient's own tissue and body to facilitate the regenerative process. By utilizing a small piece of the patient's own healthy tissue, the company produces a versatile and self-sustaining product that aims to regenerate specific tissues. PolarityTE's innovative approach is designed to enhance and accelerate the healing process through natural tissue growth.
How much funding has PolarityTE raised?
PolarityTE has raised $20.5M across 2 rounds on record. The most recent is an undisclosed round of $12.5M announced in May 2024.
When did PolarityTE last raise funding?
PolarityTE's most recent funding round on record is an undisclosed round of $12.5M, announced in May 2024.
Who founded PolarityTE?
FundedIQ lists Denver Lough (Founder) at PolarityTE.
Who is the CEO of PolarityTE?
Richard Hague is listed as CEO at PolarityTE.
Where is PolarityTE headquartered?
PolarityTE is based in Salt Lake City, Utah, United States.
How many employees does PolarityTE have?
PolarityTE is in the 11-50 employee band.
How does PolarityTE's funding compare to other Biotechnology startups?
PolarityTE's latest round of $12.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's PolarityTE Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PolarityTE is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.